Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Adel Z. Makary"'
Autor:
Richard A. Larson, Martin S. Tallman, L. Kaminer, Witold B. Rybka, Selina M. Luger, Victoria Wang, Jacob M. Rowe, Michael Craig, Judith E. Karp, Hillard M. Lazarus, Adel Z. Makary, Mark R. Litzow, Frederick R. Appelbaum, Brenda W. Cooper, Rhett P. Ketterling, Elisabeth Paietta
Publikováno v:
Leuk Res
Purpose Despite the achievement of complete remission with chemotherapy in patients with acute myeloid leukemia (AML), relapse is common and the majority of patients will die of their disease. Patients who achieve a remission after refractory or rela
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c8ed55ef23b8741734a13dc58d3bcbb
https://doi.org/10.1016/j.leukres.2021.106736
https://doi.org/10.1016/j.leukres.2021.106736
Autor:
Martin S. Tallman, F. Ann Hayes, Jacob M. Rowe, Jane L. Liesveld, Camille N. Abboud, Peter H. Wiernik, John M. Bennett, Adel Z. Makary, William R. Friedenberg, Elisabeth Paietta, Gordon W. Dewald, Donna Neuberg
Publikováno v:
Blood. 103:479-485
The optimal induction for older adults with acute myeloid leukemia (AML) is unknown. Several anthracyclines have been proposed, but the data remain equivocal. Additionally, few prospective trials of priming with hematopoietic growth factors to cycle
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b322ba5e54e945de9eea1a2db8c9b3de
https://doi.org/10.1182/blood-2003-05-1686
https://doi.org/10.1182/blood-2003-05-1686
Autor:
Albert Shamouelian, Vanessa Bolejack, Regina A. Swift, Hank H. Yang, Gargi Upadhyaya, Adel Z. Makary, Shamel Sanani, Youram Nassir, Ashkan Sefaradi, Charles M. Farber, Harry Staszewski, Ori Yellin, Donald S. Gravenor, Neil Morganstein, James D. Hilger, James R. Berenson, John Crowley, Natasha M. Tiffany, Ian W. Flinn
Publikováno v:
American journal of hematology. 86(1)
Few studies have evaluated prognostic factors among patients with multiple myeloma (MM) since new therapies have become available. Monthly zoledronic acid (ZOL) has been incorporated into many treatment regimens to reduce skeletal-related events (SRE
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f053dab8cd52aef3ea9c9f6d8da1dfa9
https://pubmed.ncbi.nlm.nih.gov/21120861
https://pubmed.ncbi.nlm.nih.gov/21120861
Autor:
Robert E. Gallagher, Peter H. Wiernik, Sandra J. Lee, Harold Londer, Olga Goloubeva, John M. Bennett, Jacob M. Rowe, Janice P. Dutcher, Adel Z. Makary, Elisabeth Paietta, J. D. Hines, John P. Farnen
Publikováno v:
Leukemialymphoma. 46(3)
The aims of this study were to evaluate the safety and efficacy of all-trans retinoic acid (ATRA) in the treatment of the accelerated and blastic phase of chronic myeloid leukemia (CML) and to evaluate in vitro correlates of biological activity. ATRA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::118c1ed97baee6978ac8d26b6f68a6fd
https://pubmed.ncbi.nlm.nih.gov/15621827
https://pubmed.ncbi.nlm.nih.gov/15621827
Publikováno v:
American journal of clinical pathology. 96(3)
Heparin-associated thrombocytopenia with thrombosis (HATT) is an uncommon syndrome that is estimated to occur in 1-5% of patients with heparin-induced thrombocytopenia. Early diagnosis requires careful clinical surveillance, and the management of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5010df6581a7cdd797836bd028e0a3b2
https://pubmed.ncbi.nlm.nih.gov/1877539
https://pubmed.ncbi.nlm.nih.gov/1877539
Autor:
Lavanya Aribandi, Adel Z. Makary
Publikováno v:
Blood. 108:5071-5071
Extramedullary tumors are a rare manifestation of multiple myeloma. Approximately half of these are present at initial diagnosis and the rest occur during the course of the disease. Pancreas is rarely involved by multiple myeloma and the diagnosis is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6193175ebf9d72f6e9198819f9559df0
https://doi.org/10.1182/blood.v108.11.5071.5071
https://doi.org/10.1182/blood.v108.11.5071.5071
Autor:
Adel Z. Makary, Robert H. Kough
Publikováno v:
Blood. 52:532-536
Two cases of multiple myeloma (MM) developed late in the course of chronic lymphocytic leukemia (CLL). An 81-yr-old white female developed, after 6 yr of CLL, IgAk MM with sheets of plasma cells abutting sheets of lymphocytes in the bone marrow, mult
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::36fbca6cf864cb395788ecb84158c30b
https://doi.org/10.1182/blood.v52.3.532.532
https://doi.org/10.1182/blood.v52.3.532.532